دورية أكاديمية
Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter
| العنوان: | Long-term outcome of low-activity radioiodine administration preceded by adjuvant recombinant human TSH pretreatment in elderly subjects with multinodular goiter |
|---|---|
| المؤلفون: | Giusti Massimo, Caputo Mauro, Calamia Iolanda, Bagnara Mariaclaudia, Ceresola Enrica, Schiavo Mara, Mussap Michele, Ferone Diego, Minuto Francesco, Bagnasco Marcello |
| المصدر: | Thyroid Research, Vol 2, Iss 1, p 6 (2009) |
| بيانات النشر: | BMC |
| سنة النشر: | 2009 |
| المجموعة: | Directory of Open Access Journals: DOAJ Articles |
| مصطلحات موضوعية: | Diseases of the endocrine glands. Clinical endocrinology, RC648-665 |
| الوصف: | Background Large multinodular goiter (MNG) in elderly people is a common finding which can require intervention. The long-term effect of radioiodine therapy on thyroid volume (TV) and function after recombinant human (rh) TSH pre-treatment was evaluated. Methods After baseline evaluation, 40 subjects over 60 years old with a large MNG were treated with 131 I up to the activity of 600 MBq. Nineteen patients were pretreated with rhTSH (0.1 mg on 2 consecutive days; group 1) while 21 subjects underwent treatment without rhTSH pretreatment (group 2). TV was monitored every 6–12 months by ultrasonography. The median follow-up period was 36 months. Results At the baseline, the groups matched in terms of TV, 24-h radioiodine uptake (RAIU), urinary iodine and neck complaints. The number of subjects pretreated with anti-thyroid drugs was significantly (P = 0.01) greater in group 2 than in group 1; TSH was more suppressed (P = 0.003) and f-T3 was more elevated (P = 0.005) in group 2 than in group 1 patients. RhTSH increased 24-h RAIU in group 1 up to the baseline level observed in group 2. The 131 I activity administered was similar in both groups. Adverse events were slight and similar in both groups. A permanent post-radioiodine toxic condition was reported only in 2 patients in group 2. After radioiodine therapy, hypothyroidism was observed in significantly more group 1 patients than group 2 patients (P = 0.002). While TV was reduced in both groups, the percentage TV reduction recorded at the last examination was significantly higher (P = 0.03) in group 1 than in group 2. MNG-related complaints were significantly reduced in both group 1 (P = 0.0001 vs baseline) and group 2 (P = 0.001) patients. Conclusion Low radioiodine activities after pretreatment with low-dosage rhTSH are able to reduce TV and improve MNG-related symptoms in elderly subjects. |
| نوع الوثيقة: | article in journal/newspaper |
| اللغة: | English |
| تدمد: | 1756-6614 |
| العلاقة: | http://www.thyroidresearchjournal.com/content/2/1/6Test; https://doaj.org/toc/1756-6614Test; https://doaj.org/article/fe0df311ef6447df8089017ce0fe8ed0Test |
| DOI: | 10.1186/1756-6614-2-6 |
| الإتاحة: | https://doi.org/10.1186/1756-6614-2-6Test https://doaj.org/article/fe0df311ef6447df8089017ce0fe8ed0Test |
| رقم الانضمام: | edsbas.51E9F960 |
| قاعدة البيانات: | BASE |
Full Text Finder | تدمد: | 17566614 |
|---|---|
| DOI: | 10.1186/1756-6614-2-6 |